- New feature includes AI-driven emotion and language predictions for users in real-time, hands-free without the need for eye tracker or voice control NEW YORK--(BUSINESS WIRE)--Synchron, the ...
NEW YORK--(BUSINESS WIRE)--Synchron, a category-defining brain-computer interface (BCI) company, announced today a step forward in implantable BCI technology to drive the future of neurotechnology.
As brain-computer interface developer Synchron has tried to expand how its tech links with the brain, it’s now trying to do the same with the computers. The company has reported that one of its ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Interim results from the COMMAND study evaluating the ...
Apple has worked on a new standard with Synchron on a brain-computer interface that, among other things, aids folks with disabilities, according to the Wall Street Journal. Synchron has made a ...
Synchron, the brain-computer interface (BCI) company, has announced the world’s first-ever use of Apple Vision Pro, by one of the patients implanted with the Synchron brain computer interface. Mark, a ...
A new protocol will allow users implanted with Synchron’s brain-computer interface (BCI) device to control iPhone, iPad and Apple Vision Pro directly with their thoughts without the need for physical ...
BUFFALO, N.Y. – Results of the clinical trial that assessed the safety of Synchron’s endovascular brain-computer interface in people with severe paralysis will be presented Sept. 30 at the Congress of ...
Please provide your email address to receive an email when new articles are posted on . Synchron’s brain-computer interface is implanted in a blood vessel on the surface of the motor cortex of the ...
New York-based Synchron, a brain-computer interface (BCI) company, announced it will be the first BCI company to reach native integration with Apple's new BCI Human Interface Device (BCI HID) profile ...
eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...
In an industry-first, the company Synchron and Mount Sinai Hospital in New York have enrolled their first human patient in a U.S. clinical trial called COMMAND to evaluate an endovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results